MT3 was first detected in the brain of patients with Alzheimer's disease, identified as a factor inhibiting neuronal growth in culture and called neural GIF (growth inhibitory factor) [55]. Here, MT3 is linked to early-onset autosomal dominant Alzheimer disease.